Palvella Therapeutics (PVLA) Curent Deferred Tax Liability (2013 - 2015)

Palvella Therapeutics (PVLA) has 3 years of Curent Deferred Tax Liability data on file, last reported at $24464.0 in Q3 2015.

• Quarterly Curent Deferred Tax Liability changed N/A year-over-year to $24464.0 in Q3 2015, while the trailing twelve-month figure through Sep 2015 was $24464.0 (changed N/A YoY) and the FY2014 annual result came in at $26522.0, up 40.5% from the prior year.
• Curent Deferred Tax Liability was little changed at $24464.0 in Q3 2015 per PVLA's latest filing, from $24446.0 in the prior quarter.
• Across five years, Curent Deferred Tax Liability topped out at $26522.0 in Q4 2014 and bottomed at $18877.0 in Q4 2013.
• The 3-year median for Curent Deferred Tax Liability is $24446.0 (2015), against an average of $23570.0.
• Peak annual rise in Curent Deferred Tax Liability reached 40.5% in 2014, while the deepest fall reached 40.5% in 2014.
• Tracing PVLA's Curent Deferred Tax Liability over 3 years: stood at $18877.0 in 2013, then jumped by 40.5% to $26522.0 in 2014, then declined by 7.76% to $24464.0 in 2015.
• Per Business Quant, the three latest PVLA Curent Deferred Tax Liability figures stand at $24464.0 (Q3 2015), $24446.0 (Q2 2015), and $23541.0 (Q1 2015).

Peer Comparison